Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD4 Deficiency”

305 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 305 results

Not applicableStudy completedNCT02934022
What this trial is testing

Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected Patients

Who this might be right for
HIV Infection
Southern California Institute for Research and Education 25
Testing effectiveness (Phase 2)Temporarily pausedNCT03312244
What this trial is testing

Pyridostigmine as Immunomodulator in People Living With HIV

Who this might be right for
HIV-1-infectionCD4+ T LymphocytopeniaImmune Deficiency+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 60
Not applicableStudy completedNCT00000883
What this trial is testing

Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 636
Not applicableStudy completedNCT00002155
What this trial is testing

A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 600
Early research (Phase 1)Study completedNCT00000667
What this trial is testing

A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT01048372
What this trial is testing

Observational Study of Blood Treated With Cytolin

Who this might be right for
HIV Infections
CytoDyn, Inc. 20
Not applicableStudy completedNCT00025922
What this trial is testing

Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 240
Post-approval studies (Phase 4)Study completedNCT00875368
What this trial is testing

Maraviroc Immune Recovery Study

Who this might be right for
HIV Infections
S.F.L. van Lelyveld 85
Testing effectiveness (Phase 2)Study completedNCT00002435
What this trial is testing

Thymic Humoral Factor (THF Gamma 2) in HIV-Infected Patients

Who this might be right for
HIV Infections
Pharmacia
Testing effectiveness (Phase 2)Study completedNCT00390078
What this trial is testing

Single-Blind, Controlled Safety and Immunogenicity Study of Recombinant MVA Virus to Treat HIV Infection

Who this might be right for
HIV Infections
Bavarian Nordic 30
Not applicableStudy completedNCT00002236
What this trial is testing

Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients

Who this might be right for
HIV Infections
Pharmacia and Upjohn 32
Testing effectiveness (Phase 2)Ended earlyNCT00839436
What this trial is testing

Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE)

Who this might be right for
Idiopathic CD4+ T-Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 21
Early research (Phase 1)Study completedNCT00000728
What this trial is testing

Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Study completedNCT00002359
What this trial is testing

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

Who this might be right for
HIV Infections
The Immune Response Corporation 3,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT03519464
What this trial is testing

Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia

Who this might be right for
Idiopathic CD4 T Cell Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 54
Testing effectiveness (Phase 2)Study completedNCT00011037
What this trial is testing

ALVAC-HIV vCP1452 Alone and Combined With MN rgp120

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 160
Testing effectiveness (Phase 2)Study completedNCT00251537
What this trial is testing

A Pilot Study of LTB4 in HIV-1 Infected Adults

Who this might be right for
HIV Infections
LTB4 Sweden AB 40
Not applicableStudy completedNCT00100581
What this trial is testing

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 2
Not applicableStudy completedNCT00688311
What this trial is testing

Pilot Trial of a Synbiotic in HIV+ Patients

Who this might be right for
HIV Infection
University of California, Davis 34
Large-scale testing (Phase 3)Study completedNCT01370018
What this trial is testing

Therapy to Elevate CD4 Counts in HIV-1 Disease

Who this might be right for
HIV Disease
Institute for Human Genetics and Biochemistry 4
Load More Results